130 related articles for article (PubMed ID: 32198527)
1. Anomalous signal intensity increase on out-of-phase chemical shift imaging: a manifestation of marrow mineralisation?
van Vucht N; Santiago R; Pressney I; Saifuddin A
Skeletal Radiol; 2020 Aug; 49(8):1269-1275. PubMed ID: 32198527
[TBL] [Abstract][Full Text] [Related]
2. Comparison of in-phase and opposed-phase T1W gradient echo and T2W fast spin echo dixon chemical shift imaging for the assessment of non-neoplastic, benign neoplastic and malignant marrow lesions.
Saifuddin A; Shafiq H; Malhotra K; Santiago R; Pressney I
Skeletal Radiol; 2021 Jun; 50(6):1209-1218. PubMed ID: 33196854
[TBL] [Abstract][Full Text] [Related]
3. Role of in-phase and out-of-phase chemical shift MRI in differentiation of non-neoplastic versus neoplastic benign and malignant marrow lesions.
van Vucht N; Santiago R; Pressney I; Saifuddin A
Br J Radiol; 2021 Mar; 94(1119):20200710. PubMed ID: 33571012
[TBL] [Abstract][Full Text] [Related]
4. Focal nodular marrow hyperplasia: Imaging features of 53 cases.
Rajakulasingam R; Saifuddin A
Br J Radiol; 2020 Aug; 93(1112):20200206. PubMed ID: 32463293
[TBL] [Abstract][Full Text] [Related]
5. In-phase and opposed-phase Dixon chemical shift imaging for the assessment of skeletal marrow lesions: comparison of measurements from longitudinal sequences to those from axial sequences.
Saifuddin A; Ali M; Santiago R; Pressney I
Br J Radiol; 2024 Mar; 97(1156):828-833. PubMed ID: 38321150
[TBL] [Abstract][Full Text] [Related]
6. Chemical shift imaging with in-phase and opposed-phase sequences at 3 T: what is the optimal threshold, measurement method, and diagnostic accuracy for characterizing marrow signal abnormalities?
Kumar NM; Ahlawat S; Fayad LM
Skeletal Radiol; 2018 Dec; 47(12):1661-1671. PubMed ID: 29936558
[TBL] [Abstract][Full Text] [Related]
7. Advanced MR imaging of bone marrow: quantification of signal alterations on T1-weighted Dixon and T2-weighted Dixon sequences in red marrow, yellow marrow, and pathologic marrow lesions.
Sasiponganan C; Yan K; Pezeshk P; Xi Y; Chhabra A
Skeletal Radiol; 2020 Apr; 49(4):541-548. PubMed ID: 31606776
[TBL] [Abstract][Full Text] [Related]
8. The Dixon technique for MRI of the bone marrow.
van Vucht N; Santiago R; Lottmann B; Pressney I; Harder D; Sheikh A; Saifuddin A
Skeletal Radiol; 2019 Dec; 48(12):1861-1874. PubMed ID: 31309243
[TBL] [Abstract][Full Text] [Related]
9. Utilization of chemical shift MRI in the diagnosis of disorders affecting pediatric bone marrow.
Winfeld M; Ahlawat S; Safdar N
Skeletal Radiol; 2016 Sep; 45(9):1205-12. PubMed ID: 27179650
[TBL] [Abstract][Full Text] [Related]
10. Benign and malignant processes: normal values and differentiation with chemical shift MR imaging in vertebral marrow.
Zajick DC; Morrison WB; Schweitzer ME; Parellada JA; Carrino JA
Radiology; 2005 Nov; 237(2):590-6. PubMed ID: 16244268
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of In-Phase and Opposed-Phase Chemical-Shift Imaging for Differentiating Benign and Malignant Vertebral Marrow Lesions: A Meta-Analysis.
Suh CH; Yun SJ; Jin W; Park SY; Ryu CW; Lee SH
AJR Am J Roentgenol; 2018 Oct; 211(4):W188-W197. PubMed ID: 30160981
[TBL] [Abstract][Full Text] [Related]
12. Value of opposed-phase gradient-echo technique in distinguishing between benign and malignant vertebral lesions.
Zampa V; Cosottini M; Michelassi C; Ortori S; Bruschini L; Bartolozzi C
Eur Radiol; 2002 Jul; 12(7):1811-8. PubMed ID: 12111073
[TBL] [Abstract][Full Text] [Related]
13. Measurement of fat content in vertebral marrow using a modified dixon sequence to differentiate benign from malignant processes.
Yoo HJ; Hong SH; Kim DH; Choi JY; Chae HD; Jeong BM; Ahn JM; Kang HS
J Magn Reson Imaging; 2017 May; 45(5):1534-1544. PubMed ID: 27690264
[TBL] [Abstract][Full Text] [Related]
14. Proton density fat fraction (PDFF) MRI for differentiation of benign and malignant vertebral lesions.
Schmeel FC; Luetkens JA; Wagenhäuser PJ; Meier-Schroers M; Kuetting DL; Feißt A; Gieseke J; Schmeel LC; Träber F; Schild HH; Kukuk GM
Eur Radiol; 2018 Jun; 28(6):2397-2405. PubMed ID: 29313118
[TBL] [Abstract][Full Text] [Related]
15. Spinal osteoblastoma: CT and MR imaging with pathological correlation.
Shaikh MI; Saifuddin A; Pringle J; Natali C; Sherazi Z
Skeletal Radiol; 1999 Jan; 28(1):33-40. PubMed ID: 10068073
[TBL] [Abstract][Full Text] [Related]
16. Benign versus pathologic compression fractures of vertebral bodies: assessment with conventional spin-echo, chemical-shift, and STIR MR imaging.
Baker LL; Goodman SB; Perkash I; Lane B; Enzmann DR
Radiology; 1990 Feb; 174(2):495-502. PubMed ID: 2296658
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of focal indeterminate marrow abnormalities with multiparametric MRI.
Baik JS; Jung JY; Jee WH; Chun CW; Kim SK; Shin SH; Chung YG; Jung CK; Kannengiesser S; Sohn Y
J Magn Reson Imaging; 2017 Jul; 46(1):49-60. PubMed ID: 27859835
[TBL] [Abstract][Full Text] [Related]
18. Role of 3T MRI in Evaluation of Bone Marrow Changes in Spine in Various Diseases.
Joshi A; Kulkarni S; Dedhia T; Vaswani A
J Assoc Physicians India; 2019 Mar; 67(3):46-51. PubMed ID: 31304706
[TBL] [Abstract][Full Text] [Related]
19. Chemical shift imaging at 3 Tesla: effect of echo time on assessing bone marrow abnormalities.
Del Grande F; Subhawong T; Flammang A; Fayad LM
Skeletal Radiol; 2014 Aug; 43(8):1139-47. PubMed ID: 24744013
[TBL] [Abstract][Full Text] [Related]
20. Gradient-echo in-phase and opposed-phase chemical shift imaging: role in evaluating bone marrow.
Dreizin D; Ahlawat S; Del Grande F; Fayad LM
Clin Radiol; 2014 Jun; 69(6):648-57. PubMed ID: 24613580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
